Vanguard Group’s ZS Pharma ZSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-1,102,116
Closed -$72.4M – 4224
2015
Q3
$72.4M Buy
1,102,116
+136,127
+14% +$8.17M 0.01% 1652
2015
Q2
$50.6M Buy
965,989
+131,404
+16% +$6.47M ﹤0.01% 1940
2015
Q1
$35.1M Buy
834,585
+476,844
+133% +$21.8M ﹤0.01% 2089
2014
Q4
$14.9M Buy
357,741
+28,518
+9% +$1.13M ﹤0.01% 2376
2014
Q3
$12.9M Buy
+329,223
New +$10.9M ﹤0.01% 2383

Vanguard Group's ZSPH Position: Q4 2015 in Review

Vanguard Group sold out of ZS Pharma (ZSPH) in Q4 2015, closing a stake of 1,102,116 shares — an estimated $72.4M sold.

Vanguard Group first reported a position in ZSPH in Q3 2014 and held it in 5 quarters. The position peaked at $72.4M in Q3 2015. 0 funds tracked by Wall St. Rank hold ZSPH as of Q4 2015.

  • Vanguard Group reported no remaining ZS Pharma position as of Q4 2015 after selling out during the quarter.
  • Vanguard Group sold 1,102,116 ZS Pharma shares in Q4 2015, an estimated $72.4M.
  • Vanguard Group first reported a position in ZS Pharma in Q3 2014 and held it in 5 quarters.
  • Vanguard Group's ZS Pharma position peaked at $72.4M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held ZS Pharma as of Q4 2015.

Based on Vanguard Group's 13F filing for Q4 2015, filed 8 Feb 2016.